The Intake Bottleneck Is Costing Plaintiff Firms More Than They Realize

Mass tort client intake is the operational stage at which a plaintiff firm's advertising investment is either converted into signed retainers or lost to competitor firms and claimant attrition. Across active dockets in 2026, firms are spending between $500 and $2,000 per acquired client, making intake efficiency a direct driver of case economics. The difference between a 20 percent and a 40 percent contact-to-sign conversion rate can determine whether a docket is profitable before the first settlement dollar arrives.

This post is about the operational and economic side of that problem, what good intake looks like for a mass tort practice, what it costs, and where firms consistently leave money on the table.

What Mass Tort Client Intake Actually Is and Why It Drives Your Bottom Line

Intake, in the context of mass tort litigation, is the full sequence of steps between a lead arriving (call, form fill, text, chat) and a signed, qualified retainer agreement landing in your case management system. It includes first contact, initial qualification screening, follow-up sequences, retainer delivery, and executed agreement collection.

Most firms understand this at a surface level, but many do not treat it as a revenue function with its own economics. They treat it as administrative. That is a costly frame. The signed case is the asset. Everything upstream of the signed case is a cost center. Intake is the conversion engine sitting between those two things, and small improvements in conversion rate produce outsized returns at scale.

If a firm is spending $500,000 per month acquiring leads on a current active docket and converting at 8%, it is signing 40 cases per $100,000 spent (using rough math). Push that conversion rate to 12% through better intake processes and the same budget produces 60 cases. That is 50% more inventory from the same media investment, with no increase in ad spend. At typical mass tort settlement values, that delta is significant enough to fund an entire intake department rebuild many times over.

The Numbers: What Realistic Intake Economics Look Like

Let's talk benchmarks. These vary by tort, channel, and how "lead" is defined, but across the 100-plus torts and $250 million-plus in managed ad spend we have worked through at MTAA, here are the ranges firms should understand.

  • Cost per lead (CPL): Ranges from under $50 on broad consumer tort campaigns to $300 to $600-plus on tightly qualified surgical mesh, AFFF, or NEC formula cases. CPL alone tells you very little without conversion rate attached.
  • Cost per signed case (CPSC): This is the metric that matters. Across well-run intake operations, CPSC on Facebook-sourced mass tort leads typically runs $800 to $2,500 depending on the docket. Poorly run intake on the same leads can push CPSC above $5,000 on cases worth the same amount.
  • Lead-to-sign conversion rate: Top-performing firms hit 15% to 25% on warm inbound leads. Average is closer to 8% to 12%. The gap is almost entirely operational, not lead quality.
  • Speed to first contact: Response time is arguably the single highest-leverage intake variable. Studies across industries consistently show that calling a lead within five minutes versus 30 minutes produces dramatically higher contact rates. In mass tort, where plaintiff firms are competing for the same claimant pool, this is not theoretical. It is money.

Good looks like sub-five-minute first contact, multi-touch follow-up sequences running at least seven to ten days, clear qualification criteria the intake team applies consistently, and a retainer delivery and signature process that does not require a claimant to print, sign, and mail anything.

How to Execute Mass Tort Client Intake Well

The firms winning on intake have a few structural things in common. None of this is complicated, but it requires actual investment and attention from firm leadership, not just delegation to whoever answers the phones.

Build Intake Around Speed and Redundancy

Every lead needs an immediate automated acknowledgment (text and email) within seconds of submission, followed by a live call attempt within five minutes during business hours. After hours, that means a call back at 8 a.m. the next morning, not "when someone gets to it." Redundancy means multiple contact channels running simultaneously. If the phone does not connect, an SMS follow-up goes out. If SMS does not get a response, email continues the sequence. The follow-up sequence should run 10 to 14 days before a lead is considered exhausted.

Separate Qualification from Conversion

Intake staff who are responsible for both initial screening and signing claimants often do neither well. High-volume mass tort intake benefits from a two-stage model: a screening layer that quickly determines basic eligibility criteria (product exposure, diagnosis, timeframe) and passes qualified leads to a closer whose job is retainer execution. This mirrors sales operations in any high-volume environment and produces materially better results than having generalists handle the full funnel.

Use Technology Where It Accelerates, Not Where It Replaces Judgment

AI-powered tools can now handle initial intake screening conversations with meaningful accuracy, flag incomplete submissions for follow-up, and route leads based on qualification score before a human ever touches the file. Firms that have integrated these tools into their intake workflow, whether through purpose-built legal intake platforms or custom-configured solutions, report significant improvements in contact rate and staff efficiency. For firms interested in the practical application of AI in these workflows, this is one of the areas covered in depth in "A Lawyer's Guide to AI," which walks through realistic implementation, not just theory.

E-signature and Remote Retainer Execution

This should be obvious in 2025, but a meaningful percentage of firms still create friction in retainer execution. The claimant should be able to review and sign on a phone. The process should take under three minutes. Every additional step between verbal commitment and executed retainer is attrition.

Pitfalls and Compliance: Where Firms Get Burned

Mass tort client intake operates inside a regulatory environment that has real teeth. The two areas that create the most exposure for firms are bar rule compliance around advertising and lead sourcing, and federal and state communication law compliance in follow-up sequences.

On the bar side, the primary risk is receiving leads from sources that do not comply with your state's advertising rules, or from aggregators who are generating leads in ways that constitute improper solicitation. Buying leads without understanding how they were generated creates bar complaint exposure. Firms should know their lead sources and have documentation on advertising methodology.

TCPA (Telephone Consumer Protection Act) and CIPA (California Invasion of Privacy Act) exposure has grown substantially. Autodialing or sending automated SMS to individuals who have not provided express written consent to be contacted can generate class action exposure that dwarfs whatever you spent on leads. Follow-up sequences need to be built with proper consent structures in place at the point of lead capture, and documented.

Hiring referral intake firms or lead aggregators without due diligence on their consent and sourcing practices is one of the fastest ways to turn a profitable campaign into a liability. Price is not a substitute for provenance.

How MTAA Approaches This for Plaintiff Firms

At Mass Tort Ad Agency, intake is not an afterthought to the advertising. The campaign and the intake system are designed together, because a high-performing ad campaign feeding a broken intake operation is just a faster way to waste the budget.

We work exclusively with plaintiff firms and referral operations. Our pricing model is transparent: ad spend plus a 15% management fee, no markup on media, no hidden charges. Across 600-plus firms and more than $250 million in managed spend, we have seen every intake configuration that works and most of the ones that do not. We can tell a firm pretty quickly where their cost per signed case is likely landing and what operational changes would move it.

We also advise on the AI tools that are genuinely useful in intake workflows versus the ones that add complexity without improving outcomes, and that practical filter matters more than it might seem when vendors are pitching aggressively.

The Firms That Win Are the Ones That Treat Intake as a System

Mass tort client intake is not a support function. It is a core revenue driver, and it deserves the same analytical attention a firm applies to its settlement strategy or litigation budget. The economics are clear: better intake produces more signed cases from the same media spend, which means lower effective cost per case and higher margin on every campaign dollar invested. The firms that have figured this out are compounding that advantage every month. The ones still treating intake as overhead are paying for leads they are not fully monetizing. Getting mass tort client intake right is not complicated, but it does require treating it like the business-critical function it actually is.

Ready to Build Your Caseload?

Get a free campaign analysis from Mass Tort Ad Agency.

$250M+ in mass tort Facebook ad spend. 600+ law firms served. Transparent cost-plus pricing with no hidden fees.

Schedule a Free Consultation →

Frequently Asked Questions: Mass Tort Client Intake

What is the average cost per signed retainer in mass tort intake, and how should plaintiff firms evaluate their acquisition economics?

Cost per signed retainer in mass tort cases typically ranges from a few hundred dollars to over two thousand dollars depending on the docket, media channel, and intake conversion efficiency. Firms should measure cost per signed case rather than cost per lead, since a low CPL paired with a poor contact-to-sign rate often produces worse acquisition economics than a higher CPL with a high-converting intake operation. Understanding that ratio is the first step toward identifying whether budget is being lost in media or lost inside intake.

Is there still enough unrepresented claimant volume in active mass tort dockets to justify scaling intake operations now?

Several active dockets, including those tied to talc, AFFF, and hair relaxer litigation, still have large populations of unrepresented eligible claimants who have not yet retained counsel. Plaintiff-side demand remains strong and sign rates favor firms that can move quickly, since many eligible individuals are being contacted by multiple firms simultaneously. Firms that build scalable intake infrastructure now are positioned to capture a disproportionate share of remaining volume before dockets mature and acquisition costs climb further.

Which advertising channels produce the highest-quality mass tort leads, and how does a cost-plus media model protect plaintiff firms from inflated spend?

Facebook and Instagram remain the dominant channels for mass tort lead generation due to their targeting capabilities around demographics, health conditions, and product usage history, while YouTube and programmatic display are increasingly effective for retargeting and awareness. A cost-plus media model, where the intake or marketing partner charges a transparent markup over actual ad spend rather than a flat CPL, gives plaintiff firms full visibility into where dollars are going and aligns incentives around efficiency rather than volume. This structure prevents the common problem of inflated CPL pricing that obscures poor media performance behind a single blended number.

What does a high-performing mass tort intake operation look like operationally, and where do most plaintiff firms lose signed cases?

A high-performing intake operation contacts inbound leads within minutes, runs a structured qualification script, delivers retainer agreements digitally within the same interaction, and has automated follow-up sequences for leads that do not sign immediately. Most firms lose signed cases in three places: slow first-contact response that allows a competing firm to reach the claimant first, unqualified intake staff who cannot handle objections or legal questions, and retainer delivery processes that create friction or delay. Treating intake as a revenue function with staffing, scripting, and technology built specifically for volume is what separates firms that convert at fifteen percent versus those converting at forty percent or higher.

How should plaintiff firm owners think about building versus outsourcing mass tort intake, and what are the key operational tradeoffs?

Building intake in-house gives a firm direct control over staff training, script quality, and data ownership, but requires significant investment in hiring, management, technology infrastructure, and the operational expertise to run high-volume lead response efficiently. Outsourcing to a specialized intake vendor or co-counsel intake partner can compress the time to a functioning operation and is often more cost-effective at lower monthly lead volumes, but introduces dependency on a third party's staffing quality and incentive alignment. The right answer depends on the firm's monthly lead volume, available management bandwidth, and whether intake is intended to be a long-term core competency or a variable-cost function tied to specific docket campaigns.